Post-approval studies (Phase 4)Study completedNCT00090038
What this trial is testing
Effect of Rituximab on Immunological Recall Response to Specific Antigens in the Treatment of Non-Hodgkin's Lymphoma
Who this might be right for
Non-Hodgkin's Lymphoma
Biogen 168